Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Cash flows from operating activities
Net loss for the year	$ (35,444,361)	$ (11,155,516)
Adjustments to reconcile net loss to net cash used in operating activities
Stock-based compensation expense	1,512,194	713,119
Non-cash interest expense	429,061	74,005
Change in operating lease right-of-use assets	97,838	88,234
Change in fair value of debentures	583,823	0
Loss of extinguishment of debentures	25,000	0
IPR&D - Teverelix	8,717,475	0
Foreign exchange gain/loss	41,947	0
Loss on SEPA settlements	278,854	0
Issuance cost related to SEPA	300,000	0
Cost of issuance of debentures	111,725	0
Changes in operating assets and liabilities:
Prepaid expenses	352,825	(1,040,265)
Deferred financing costs	(99,305)	0
Accounts payable	923,552	808,745
Accrued expenses and other current liabilities	(438,802)	358,018
Operating lease liability	(142,612)	(70,080)
Related party payable	(25,983)	(23,491)
Net cash used in operating activities	(22,776,769)	(10,247,231)
Cash flows from financing activities
Proceeds from issuance of convertible promissory notes	0	5,172,500
Proceeds from initial public offering, net of offering expenses	0	2,049,716
Proceeds from issuance of common shares and warrants, net of issuance costs	9,790,015	5,470,000
Proceeds from issuance of debentures	11,866,293	0
Repayment of the debentures and other loan	(7,391,107)	0
Proceeds from issuance of common shares under SEPA	8,427,416	0
Proceeds from exercise of warrants	9,874,998	0
Proceeds from exercise of stock options	162,400	0
Costs to issue debentures	(136,726)	0
Issuance costs for common shares	(653,504)	0
Net cash provided by financing activities	31,939,785	12,692,216
Cash flows from investing activities
Net cash paid for Antev asset acquisition including transaction costs	(4,619,152)	0
Net cash used in investing activities	(4,619,152)	0
Foreign currency effect on cash and cash equivalents	(2,969)	0
Net increase in cash and cash equivalents during the year	4,540,895	2,444,985
Cash and cash equivalents, beginning of the year	4,164,323	1,719,338
Cash and cash equivalents, end of the year	8,705,218	4,164,323
Supplemental information
Cash paid for interest	221,663	40,563
Supplemental disclosure of non-cash investing and financing activities
Right-of-use assets obtained in exchange for lease liabilities	0	356,805
Deemed dividend on warrant inducement	11,837,298	0
Issuance costs included in accounts payable	95,360	265,025
Shares issued for Antev asset acquisition	2,129,410	0
Shares to be issued for Antev asset acquisition	313,934	0
Issuance of shares related to SEPA agreement	300,000	0
Accrued interest converted into common shares	$ 0	$ 38,462